Adult Malignant Glioma Therapeutics Market 2019 Global Industry Analysis by Trends, Size, Share, Company Overview, Growth and Forecast by 2025

1

• Adult Malignant Glioma Therapeutics Market 2019
  Industry Size by Global Major Companies
  Profile, Competitive Landscape and Key Regions
  2025
• The Global Adult Malignant Glioma Therapeutics
  Market is likely to grow in the coming years due
  to advancements made in targeted therapy to treat
  malignant glioma. According to a report
  published by Fortune Business Insights, titled
  Adult Malignant Glioma Therapeutics Global
  Market Analysis, Insights and Forecast,
  2019-2026, the market was valued at US 1,459.1
  Mn. Fortune Business Insights states that the
  market is likely to reach US 2,964.5 Mn at a
  CAGR of 9.3 in the forecast period.
• Sample PDF Brochure at https//www.fortunebusiness
  insights.com/industry-reports/adult-
  malignant-glioma-therapeutics-market-100572
• Some of the leading companies that are operating
  in the Global Adult Malignant Therapeutics
  Market are
• Merck Co., Inc.
• F. Hoffmann-La Roche Ltd
• Arbor Pharmaceuticals
• Pfizer Inc.
• AbbVie Inc.
• Amgen Inc.
• Bristol-Myers Squibb Company
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd. and Novocure.
• According to the World Health Organization (WHO),
  almost 2,45,000 brain tumor cases are registered
  every year. Despite advancements in treatment
  options and awareness regarding prevention of
  tumor at an early stage, the incidence of brain
  tumor has been on the rise. With increasing
  glioma cases and a low survival rate among people
  diagnosed with glioma, there are several market
  players focusing solely on the research and
  development of novel therapeutics to treat adult
  malignant glioma. The aforementioned factors are
  driving the global adult malignant glioma
  therapeutics market.
• New Imaging Technique May Help Remove Malignant
  Tumor Altogether
• Researchers have come up with a new imaging
  technique that may help in eliminating the
  malignant tumor from the human body, altogether.
  This imaging method may help surgeons locate the
  tumor with ease. Researchers have claimed that
  this technique involves the use of a synthetic
  version of a molecular compound found in the
  venom of a scorpion. The method also involves
  the use of an infra-red (IR) camera along with an
  imaging reagent tozuleristide (BLZ-100). The
  primary aim of this method was to determine the
  boundaries between a healthy tissue and tumor.
  This helps in retaining the healthy tissue after
  the surgery and thus

2
increases the efficiency of the overall process.
Such discoveries are likely to favour growth of
the global adult malignant glioma therapeutics
market in the forthcoming years. Blue Earth
Announces FDA Clearance for Glioma Drug In
December 2018, Blue Earth announced that it has
received FDA clearance for a new drug Axumin,
which has application in positron emission
tomography (PET) imaging for removing tumors.
The company announced that Fluciclovin (or
Axumin) enables PET imaging that may help detect
the precise location of the tumor within the
body. Along with precise location, the size and
severity of tumor can also be traced. This will
massively help in treating the malignant glioma
disorder and reduce the overall fatality rate
among people diagnosed with this disorder. Thus,
the FDA approval will help the company take huge
strides towards their aim of developing an
efficient malignant glioma treatment method. Blue
Earths success may have impact on the global
adult malignant glioma therapeutics market and
will lead to growth of the market in the coming
years. Browse Complete Report Details at
https//www.fortunebusinessinsights.com/industry-
reports/adult-malignant-glioma-therapeutics-marke
t-100572 About Us Fortune Business Insights
offers expert corporate analysis and accurate
data, helping organizations of all sizes make
timely decisions. We tailor innovative solutions
for our clients, assisting them address
challenges distinct to their businesses. Our goal
is to empower our clients with holistic market
intelligence, giving a granular overview of the
market they are operating in. Our reports
contain a unique mix of tangible insights and
qualitative analysis to help companies achieve
sustainable growth. Our team of experienced
analysts and consultants use industry-leading
research tools and techniques to compile
comprehensive market studies, interspersed with
relevant data. At Fortune Business Insights we
aim at highlighting the most lucrative growth
opportunities for our clients. We therefore
offer recommendations, making it easier for them
to navigate through technological and
market-related changes. Our consulting services
are designed to help organizations identify
hidden opportunities and understand prevailing
competitive challenges. Contact Us Fortune
Business Insights Pvt. Ltd. 308, Supreme
Headquarters,
3
Survey No. 36, Baner, Pune-Bangalore
Highway, Pune - 411045, Maharashtra,
India. Phone US 1 424 253 0390 UK 44 2071
939123 APAC 91 744 740 1245 Email
sales_at_fortunebusinessinsights.com